Emerald Acquisition Ltd. - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 116 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Emerald Acquisition Ltd. ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2016$778,000
+179.9%
122,862
+86.4%
0.00%–
Q2 2016$278,000–65,928–0.00%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q3 2016.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders